Newsfile Corp
09 Jul 2026, 01:57 UTC · 18w ago
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Impact · against what's priced in
ADMA Biologics faces significant valuation risk due to a class action lawsuit alleging channel stuffing and internal control failures. Because these allegations target the integrity of reported revenue and corporate governance, they represent a material negative catalyst for the stock.
- ADMA−0.70
No priced-in read yet





